Related Experiment Video
Updated: Jun 10, 2025
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression
Benjamin Schwartzmann1, Raaj Chatterjee1, Yasaman Vaghei1
1eBrain Lab, School of Mechatronic Systems Engineering, Simon Fraser University, Surrey, British Columbia, Canada.
Abstract:
Current pharmacological agents for depression have limited efficacy in achieving remission. Developing and validating new medications is challenging due to limited biological targets. This study aimed to link electrophysiological data and symptom improvement to better understand mechanisms underlying treatment response. Longitudinal changes in neural oscillations were assessed using resting-state electroencephalography (EEG) data from two Canadian Biomarker Integration Network in Depression studies, involving pharmacological and cognitive behavioral therapy (CBT) trials. Patients in the pharmacological trial received eight weeks of escitalopram, with treatment response defined as ≥ 50% decrease in Montgomery-Åsberg Depression Rating Scale (MADRS). Early (baseline to week 2) and late (baseline to week 8) changes in neural oscillation were investigated using relative power spectral measures. An association was found between an initial increase in theta and symptom improvement after 2 weeks. Additionally, late increases in delta and theta, along with a decrease in alpha, were linked to a reduction in MADRS after 8 weeks. These late changes were specifically observed in responders. To assess specificity, we extended our analysis to the independent CBT cohort. Responders exhibited an increase in delta and a decrease in alpha after 2 weeks. Furthermore, a late (baseline to week 16) decrease in alpha was associated with symptom improvement following CBT. Results suggest a common late decrease in alpha across both treatments, while modulatory effects in theta may be specific to escitalopram treatment. This study offers insights into electrophysiological markers indicating a favorable response to antidepressants, enhancing our comprehension of treatment response mechanisms in depression.
Insights
Electroencephalography (EEG) reveals early theta increases predict symptom improvement with escitalopram. Late changes in delta, theta, and alpha oscillations indicate treatment response to both antidepressants and cognitive behavioral therapy (CBT).
Area of Science:
- Neuroscience
- Psychiatry
- Biomarkers
Background:
- Current depression treatments have limited efficacy, necessitating novel therapeutic targets.
- Understanding the biological mechanisms of treatment response is crucial for developing effective interventions.
Purpose of the Study:
- To investigate the association between longitudinal changes in neural oscillations and symptom improvement in depression.
- To identify electrophysiological markers predictive of treatment response to pharmacological (escitalopram) and cognitive behavioral therapy (CBT).
Main Methods:
- Resting-state electroencephalography (EEG) data from two independent depression cohorts (pharmacological and CBT trials) were analyzed.
- Relative power spectral measures assessed longitudinal changes in neural oscillations (delta, theta, alpha) from baseline to treatment endpoints.
- Treatment response was defined by a ≥ 50% reduction in Montgomery-Åsberg Depression Rating Scale (MADRS) scores.
Main Results:
- An early increase in theta oscillations (baseline to week 2) correlated with symptom improvement in the escitalopram group.
- Late increases in delta and theta, and a decrease in alpha oscillations (baseline to week 8) were associated with treatment response to escitalopram.
- A common late decrease in alpha oscillations was observed in responders across both escitalopram and CBT treatments, while theta changes were specific to escitalopram.
Conclusions:
- Electrophysiological markers, particularly changes in alpha oscillations, show promise in predicting favorable treatment response in depression.
- Distinct patterns of neural oscillation changes may differentiate response mechanisms between pharmacological and psychological interventions.
- This study enhances understanding of treatment response mechanisms, potentially guiding the development of personalized depression therapies.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
01:14Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...